SALT LAKE CITY — On this Healio Video Perspective from the ARVO assembly, Patrick Johnson, PhD, president of Sydnexis, shares knowledge on myopia development that’s consultant of kids within the U.S.
“In a consultant inhabitants of the U.S. — not an solely Asian inhabitants, however a inhabitants that encompasses about 20% Asians — we see a barely decrease charge of development than you see in different research,” Johnson stated. “However what’s actually fascinating is we see that 13 and 14 years previous is roughly the age the place myopia development slows down and involves a crawl.”
The info come from the part 3 STAR examine of SYD-101 (atropine sulfate ophthalmic answer 0.01% and 0.03%, Sydnexis) for the remedy of myopia development in youngsters. The examine is the “world’s largest examine for the remedy of pediatric progressive myopia ever performed,” Johnson stated.
“The FDA is at all times fascinated about a really consultant inhabitants, and that’s what we gave them,” he added.
Reference:
- Cheetham JK, et al. The pure historical past of myopia development in a big numerous pediatric inhabitants. Introduced at: Affiliation for Analysis in Imaginative and prescient and Ophthalmology assembly; Could 4-8, 2025; Salt Lake Metropolis.
Sources/Disclosures
Collapse
Johnson P, et al. Strategies and baseline knowledge from the STAR examine: A part 3 multicenter trial of SYD-101 for myopia development in 800+ youngsters. Introduced at: Affiliation for Analysis in Imaginative and prescient and Ophthalmology assembly; Could 4-8, 2025; Salt Lake Metropolis.
Disclosures:
Johnson stories being president of Sydnexis.
